News · 26 weeks55+400%
2026-03-012026-08-23
Mix1790d
- Insider9(53%)
- SEC Filings3(18%)
- Other2(12%)
- Earnings2(12%)
- Analyst1(6%)
Latest news
25 items- PRLeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceBURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. Contact: Sandra MillarLeMaitre Vascular, In
- ANALYSTLemaitre Vascular downgraded by Barrington ResearchBarrington Research downgraded Lemaitre Vascular from Outperform to Mkt Perform
- SECSEC Form 10-Q filed by LeMaitre Vascular Inc.10-Q - LEMAITRE VASCULAR INC (0001158895) (Filer)
- SECLeMaitre Vascular Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - LEMAITRE VASCULAR INC (0001158895) (Filer)
- PRLeMaitre Q2 2026 Financial ResultsBURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. Q2 2026: Sales $70.4mm, +10% (+10% organic) vs. Q2 2025Gross margin 72.1% (+210 bps)Op. income $20.4mm (+26%) Op. margin 29%EPS $0.74 (+23%)Cash up $9.0mm sequentially to $376.2mm Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the quarter due to recall-driven overstocking in Q2 2025. Q
- PRLeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of
- INSIDERSEC Form 4 filed by Director Jasinski Lawrence J4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director O'Connor John James4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Roush John A4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Shadan Martha4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Pellegrino Joseph P Jr4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Leblanc Dorian Paul4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by President and Director Roberts David B4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Senior V. P., Operations Kamke Trent G4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERChairman and CEO Lemaitre George W gifted 11,974 shares and was granted 11,974 shares, decreasing direct ownership by 0.84% to 1,418,045 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- SECLeMaitre Vascular Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - LEMAITRE VASCULAR INC (0001158895) (Filer)
- SECSEC Form SD filed by LeMaitre Vascular Inc.SD - LEMAITRE VASCULAR INC (0001158895) (Filer)
- PRLeMaitre to Participate at Upcoming Investor Conferences in JuneBURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that management will be participating in two upcoming investor conferences in June. Jefferies Global Healthcare Conference Wednesday, June 3, 2026Marriott Marquis, New York CityManagement will participate in a fireside chat at 10:30 AM EDT Goldman Sachs Annual Global Healthcare ConferenceWednesday, June 10, 2026Loews Miami Beach Hotel, Miami BeachManagement will present at 9:20 AM EDT About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company d
- INSIDERChairman and CEO Lemaitre George W sold $5,032,413 worth of shares (46,481 units at $108.27), decreasing direct ownership by 3% to 1,430,019 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSenior V. P., Operations Kamke Trent G sold $313,287 worth of shares (2,928 units at $107.00), decreasing direct ownership by 44% to 3,749 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERDirector Ross Bridget A exercised 5,044 shares at a strike of $48.15 and sold $560,366 worth of shares (5,044 units at $111.10) (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERDirector Jasinski Lawrence J exercised 2,858 shares at a strike of $65.92 and sold $433,730 worth of shares (3,943 units at $110.00), decreasing direct ownership by 19% to 4,714 units (SEC Form 4)4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- PRLeMaitre to Present at the Bank of America Healthcare ConferenceBURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 smi
- SECSEC Form 10-Q filed by LeMaitre Vascular Inc.10-Q - LEMAITRE VASCULAR INC (0001158895) (Filer)
- SECLeMaitre Vascular Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - LEMAITRE VASCULAR INC (0001158895) (Filer)
LMAT FAQ
7 questionsWhat does LeMaitre Vascular Inc. do?
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid...Where does LMAT stock trade?
LeMaitre Vascular Inc. (LMAT) is listed on NASDAQ.What sector and industry is LMAT in?
LeMaitre Vascular Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did LeMaitre Vascular Inc. go public?
LeMaitre Vascular Inc. (LMAT) completed its IPO in 2006.What are analysts saying about LMAT?
LeMaitre Vascular Inc. has had 8 recent analyst actions on file. The most recent action was from Barrington Research: Mkt Perform on 2026-08-05.What companies are similar to LMAT?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare LMAT side-by-side with any of them on Quantisnow.How can I track LMAT on Quantisnow?
Quantisnow aggregates LeMaitre Vascular Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LMAT to receive live email and push alerts on every new disclosure.